Braving the bear market - investment in psychedelic healthcare
There are strong signs Europe and North America are about to enter a recession, as sanctions against Russian oil and supply chain disruption exacerbate inflation.
In response to soaring inflation, the Federal Reserve has raised interest rates three times in six months – with further hikes expected.
High interest rates make it harder for companies to raise the capital that finances research and development, a core activity in life sciences.
This has resulted in company valuations and investment plummeting; however, the bear market presents lucrative opportunities for investors who can weather the storm.
READ MORE
